5 recommendations to achieve health sovereignty in Morocco

Health experts and doctors have made 5 recommendations to achieve health sovereignty in Morocco.

Gathered on the occasion of the fourth edition of Pharma Day, drug manufacturers, experts and government officials discussed ways to achieve health sovereignty in Morocco.

Among them were the Minister of Health Khalid Ait Taleb, the President of the Competition Council, Ahmed Rahhou, and the Director General of the National Health Insurance Agency (ANAM), Khalid Lahlou.

Special guest of this event, the Vice-President of the African Health Federation, Clare Omatseye, “welcomed the royal commitment in the context of the completion of the reform of social safety nets, emphasizing the development potential of the Moroccan pharmaceutical industry, in particular with the construction of the future Pan-African mega-factory for the manufacture of vaccines, the objective of which is to make the country an African champion”, indicated a press release from the Moroccan Federation of Industry and Pharmaceutical Innovation.

“The ZLECA, aimed at creating a single market for goods and services through the free movement of people, is therefore a great opportunity for local manufacturers, particularly in Morocco,” she said.

Regarding the reforms aimed at strengthening health sovereignty, the participants made 5 recommendations. The first consists in making the local manufacture of the drug a real catalyst for the development of the sector through the application of national preference and the optimization of the regulatory process.

Medicines experts believe that the various private actors concerned by the universal health coverage project should be involved during the implementation of its various phases, in order to ensure a continuous supply of essential medical products, as well as to create synergy between the multiple players in the drug value chain.

Finally, they recommend partnership and coordination between private and public actors in the development of health policy and the implementation of the various ongoing projects and to favor public-private partnership for better accessibility to health care. and optimal patient care.

Previous Post Next Post